Insmed To Present at November and December 2025 Investor Conferences
Insmed (Nasdaq: INSM) announced management will present at two investor conferences in November and December 2025: the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 2025 at 8:30 a.m. GT / 3:30 a.m. ET, and the Evercore 8th Annual Healthcare Conference in Coral Gables, Florida on Tuesday, December 2, 2025 at 11:15 a.m. ET.
Both presentations will be webcast live and archived for 30 days on Insmed's investor relations website at www.insmed.com.
Insmed (Nasdaq: INSM) ha annunciato che la direzione parteciperà a due conferenze per investitori nel novembre e dicembre 2025: la Jefferies Global Healthcare Conference a Londra martedì 18 novembre 2025 alle 8:30 GMT / 3:30 ET, e la Evercore 8th Annual Healthcare Conference a Coral Gables, in Florida, martedì 2 dicembre 2025 alle 11:15 ET.
Entrambe le presentazioni saranno trasmesse in diretta in webcast e saranno disponibili in archivio per 30 giorni sul sito di Relazioni con gli investitori di Insmed all'indirizzo www.insmed.com.
Insmed (Nasdaq: INSM) anunció que la dirección presentará en dos conferencias para inversores en noviembre y diciembre de 2025: la Jefferies Global Healthcare Conference en Londres el martes 18 de noviembre de 2025 a las 8:30 a.m. GT / 3:30 a.m. ET, y la Evercore 8th Annual Healthcare Conference en Coral Gables, Florida, el martes 2 de diciembre de 2025 a las 11:15 a.m. ET.
Ambas presentaciones serán transmitidas en vivo por webcast y estarán archivadas durante 30 días en el sitio de relaciones con inversores de Insmed en www.insmed.com.
인스메드(Nasdaq: INSM)는 2025년 11월과 12월에 두 차례의 투자자 회의에서 경영진이 발표할 것이라고 발표했습니다: 런던에서 열리는 Jefferies Global Healthcare Conference는 2025년 11월 18일 화요일 오전 8:30 GMT / 오전 3:30 ET, 그리고 플로리다주 코랄 게이블스에서 열리는 Evercore 8th Annual Healthcare Conference는 2025년 12월 2일 화요일 오전 11:15 ET입니다.
두 발표는 실시간 생중계로 webcast되며 Insmed의 투자자 관계 웹사이트 www.insmed.com에서 30일 동안 보관됩니다.
Insmed (Nasdaq : INSM) a annoncé que la direction participera à deux conférences investisseurs en novembre et décembre 2025 : la Jefferies Global Healthcare Conference à Londres le mardi 18 novembre 2025 à 8 h 30 GMT / 3 h 30 HE, et la Evercore 8th Annual Healthcare Conference à Coral Gables, en Floride, le mardi 2 décembre 2025 à 11 h 15 HE.
Les deux présentations seront diffusées en direct sur le web et archivées pendant 30 jours sur le site des relations investisseurs d’Insmed à l’adresse www.insmed.com.
Insmed (Nasdaq: INSM) gab bekannt, dass das Management auf zwei Investorenkonferenzen im November und Dezember 2025 präsentieren wird: die Jefferies Global Healthcare Conference in London am Dienstag, dem 18. November 2025 um 8:30 Uhr GMT / 3:30 Uhr ET, und die Evercore 8th Annual Healthcare Conference in Coral Gables, Florida, am Dienstag, dem 2. Dezember 2025 um 11:15 Uhr ET.
Beide Präsentationen werden live per Webcast übertragen und für 30 Tage auf der Investor-Relations-Website von Insmed unter der URL www.insmed.com archiviert.
إنسمد (ناسداك: INSM) أعلنت أن الإدارة ستقدّم في مؤتمرين للمستثمرين في نوفمبر وديسمبر 2025: مؤتمر جيفرز للرعاية الصحية العالمية في لندن يوم الثلاثاء 18 نوفمبر 2025 الساعة 8:30 صباحاً بتوقيت جرينتش / 3:30 صباحاً بتوقيت شرق الولايات المتحدة، ومؤتمر Evercore التاسع للأبحاث في الرعاية الصحية في كورال جابلز، فلوريدا يوم الثلاثاء 2 ديسمبر 2025 الساعة 11:15 صباحاً بتوقيت شرق الولايات المتحدة.
كلا العرضين سيكونان مباشرين عبر الويب ومؤرشفين لمدة 30 يوماً على موقع علاقات المستثمرين بشركة إنسمد على العنوان www.insmed.com.
- None.
- None.
BRIDGEWATER, N.J., Nov. 5, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences:
- Jefferies Global Healthcare Conference in London, on Tuesday, November 18, 2025, at 8:30 a.m. GT / 3:30 a.m. ET.
- Evercore 8th Annual Healthcare Conference in Coral Gables, Florida, on Tuesday, December 2, 2025, at 11:15 a.m. ET.
These events will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. Webcasts will be archived for a period of 30 days following the conclusion of the live events.
About Insmed
Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including two approved therapies to treat chronic, debilitating lung diseases. The Company's early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.
Headquartered in Bridgewater, New Jersey, Insmed has offices and research locations throughout the United States, Europe, and Japan. Insmed is proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending five consecutive years as the No. 1 Science Top Employer. Visit www.insmed.com to learn more or follow us on LinkedIn, Instagram, YouTube, and X.
Contact:
Investors:
Bryan Dunn
Vice President, Investor Relations
(646) 812-4030
investor.relations@insmed.com
Media:
Claire Mulhearn
Vice President, Corporate Communications
(862) 842-6819
media@insmed.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-november-and-december-2025-investor-conferences-302603157.html
SOURCE Insmed Incorporated
